AVIRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Atea Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$4.39+0.07 (+1.62%)
Close on Oct 19, 2026
- Market cap
- $351.42M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Atea Pharmaceuticals has not reported a dividend
No dividend per share appears in Atea Pharmaceuticals's annual filings since fiscal 2017.